IMM 1.45% 34.0¢ immutep limited

chinese competitor dendritic-cell therapy, page-4

  1. 3,401 Posts.
    lightbulb Created with Sketch. 72
    without passing judgement on the content reschard, the case studies presented on that site show no discussion of:
    -follow up therapy completed,
    -longevity of outcomes, -
    -discussion of side effects,
    -probability of quality outcome,(obviously no discussion of unfavourable outcome)
    - relation of offered treatment to previously completed unrelated treatments per patient, chemo etc

    the expedient path that contemporary chinese medicine has taken as opposed to the more thorough western approach leaves the prospective client open to a world of subjectivity.
    costs are listed at average 30-40k us, before extras including transfusions, albumin. 60 days in china also required, often longer.
    it is however of course interesting reading, thank you for the link reschard.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.